Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


Strengths

● Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● The company benefits from high valuations in earnings multiples.

● With an enterprise value anticipated at 5.01 times the sales for the current fiscal year, the company turns out to be overvalued.

● The company appears highly valued given the size of its balance sheet.

● The company is highly valued given the cash flows generated by its activity.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.